Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.

MLA

Astuti, Dewi, et al. “Mutation Analysis of HIF Prolyl Hydroxylases (PHD/EGLN) in Individuals with Features of Phaeochromocytoma and Renal Cell Carcinoma Susceptibility.” Endocrine-Related Cancer, vol. 18, no. 1, Dec. 2010, pp. 73–83. EBSCOhost, https://doi.org/10.1677/ERC-10-0113.

APA

Astuti, D., Ricketts, C. J., Chowdhury, R., McDonough, M. A., Gentle, D., Kirby, G., Schlisio, S., Kenchappa, R. S., Carter, B. D., Kaelin, W. G., Jr, Ratcliffe, P. J., Schofield, C. J., Latif, F., & Maher, E. R. (2010). Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocrine-Related Cancer, 18(1), 73–83. https://doi.org/10.1677/ERC-10-0113

Chicago

Astuti, Dewi, Christopher J Ricketts, Rasheduzzaman Chowdhury, Michael A McDonough, Dean Gentle, Gail Kirby, Susanne Schlisio, et al. 2010. “Mutation Analysis of HIF Prolyl Hydroxylases (PHD/EGLN) in Individuals with Features of Phaeochromocytoma and Renal Cell Carcinoma Susceptibility.” Endocrine-Related Cancer 18 (1): 73–83. doi:10.1677/ERC-10-0113.